Alzheimer Disease: Diffusion Tensor MRI ...

Dr. Lauren Kim speaks with first author Dr. Andrew Hernandez about his study which comprehensively quantified energy consumption in MRI, CT, and PET/CT imaging suites by measuring the energy utilization of main power, HVAC, and chilled water subsystems. The study showed that HVAC ... Show More

Host Dr. Reni Butler sits down with Dr. Connie Lehman to discuss groundbreaking research on how AI-generated breast cancer risk scores change over time and what those changes may reveal about a woman's future cancer risk. Together, they explore the promise of longitudinal imaging ... Show More

Dr. Refky Nicola welcomes back Dr. Kate Hanneman to discuss new research examining the link between long-term air pollution exposure and coronary atherosclerosis detected on cardiac CT. Together, they explore key findings on plaque burden, sex-specific differences, cumulative exp ... Show More

<p>In this interview, dementia expert Gil D. Rabinovici, MD, discusses monoclonal antibodies that target beta-amyloid–-including a recent phase 3 trial of donanemab published in JAMA-–and reviews considerations for their use in patients with Alzheimer disease.<br /> <br /> <stron ... Show More

Dr. Rae Bacharach discusses the Neurology Today article, "Individuals Can Now Request a Blood Test for Alzheimer disease - Why Some Dementia Experts Are Wary". Show references: https://journals.lww.com/neurotodayonline/fulltext/2023/10190/individuals_can_now_request_a_blood_test_ ... Show More

Dr. Greg Cooper talks with Dr. Joseph Therriault about the use of plasma biomarkers in diagnosing Alzheimer disease, emphasizing the importance of interpreting these biomarkers within the clinical context of the patient. Read the related article in Nature. Disclosures can be foun ... Show More

<p class="MsoNormal">This episode is a conversation with Drs. Clifford Jack and Kevin Duff about recent updates to the diagnosis and staging of Alzheimer's disease (AD). We discuss biological versus clinical/pathological approaches to diagnosing AD, analogies between AD and other ... Show More

<p>Dr. Trey Bateman talks with Dr. Amy Brodtmann about the complexities of diagnosing FTD and related disorders, emphasizing the need to understand frontal network impairments and the importance of behavioral assessments and psychiatric history in clinical practice.</p> <p>Read t ... Show More

There are 6 million Americans living with Alzheimer's Disease. This program explains the latest understanding of the anatomy and functions of the brain and how it relates to neurological diseases. Dr. Gil Rabinovici is at the forefront of novel diagnostic testing to detect Alzhei ... Show More

Dr. Jason Crowell talks with Dr. Christopher Gibbons to discuss his paper "Cutaneous Phosphorylated Alpha-Synuclein Deposition in Dementia with Lewy Bodies and Mild Cognitive Impairment."   Show reference:  https://index.mirasmart.com/AAN2024/SearchResults.php?Program_Number=PL4. ... Show More

This episode explores the current state of research on the multiple likely mechanisms of Alzheimer’s disease as well as promising treatments and diagnostics. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2309944. 

Dr. Kenneth Langa discusses his paper, "Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US". Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2797274?resultClick=1 This episode is brought to you by Mass General Brigham De ... Show More

In part 1 of a 3 part series, Cyrus A. Raji, MD, Ph.D., discusses his article, "The Value of Neuroimaging in Dementia Diagnosis" from the June Continuum Dementia issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/Neuro ... Show More